Pet Health Screening Market - Global Forecast 2026-2032

List of Tables

The Pet Health Screening Market is projected to grow by USD 8.65 billion at a CAGR of 15.36% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 3.18 billion
Estimated Year [2026]	USD 3.55 billion
Forecast Year [2032]	USD 8.65 billion
CAGR (%)	15.36%

Pet Health Screening: Executive Overview

Pet health screening encompasses preventive checks, diagnostic testing, and routine monitoring intended to identify disease risks and support earlier veterinary intervention. Its importance is increasing as owners place greater emphasis on animal wellbeing, preventive care, and informed treatment decisions. Screening may include physical examinations, laboratory analysis, imaging, genetic assessments, parasite checks, and condition-specific monitoring, depending on species, age, health status, and veterinary guidance.

Preventive Care Is Reshaping Pet Health Screening

The landscape is shifting from episodic treatment toward more continuous, risk-based prevention. Greater awareness of chronic disease, aging-related conditions, zoonotic risks, and the value of early detection is encouraging structured wellness visits and more targeted testing. Digital appointment systems, electronic medical records, home-monitoring tools, and improved laboratory workflows are also supporting more coordinated care. Adoption remains shaped by affordability, owner education, veterinary capacity, animal stress, and differences in preventive-care practices across geographies.

Artificial Intelligence Strengthens Triage and Diagnostic Workflows

Artificial intelligence is increasingly relevant to image interpretation, laboratory pattern recognition, symptom triage, risk stratification, and clinical decision support. Its cumulative impact is most useful when it improves consistency, prioritizes cases, and helps veterinarians interpret large or complex datasets rather than replacing professional judgment. Responsible deployment requires representative veterinary data, transparent validation, privacy safeguards, cybersecurity, clear accountability, and controls against false positives or missed conditions. Integration with practice-management and diagnostic systems will determine whether these tools produce durable operational value.

Regional Insights Across Six Distinct Care Environments

North America is characterized by established companion-animal care infrastructure, relatively broad diagnostic access, and strong interest in preventive services, while Latin America presents varied access conditions and opportunities to expand routine screening through cost-conscious, scalable models. Europe combines mature veterinary systems with strong attention to animal welfare, data governance, and cross-border standards. The Middle East is shaped by uneven provider availability, expanding urban pet ownership, and demand for dependable specialist and preventive services. Africa requires approaches adapted to affordability, workforce distribution, infectious-disease priorities, and mixed companion-animal and livestock contexts. Asia-Pacific spans highly advanced urban markets alongside developing systems, making mobile services, tele-support, education, and tiered diagnostics particularly relevant.

Group Insights: Regulation, Trade, and Care-System Differences

ASEAN markets reflect substantial variation in veterinary infrastructure, urbanization, household income, and regulatory maturity, favoring adaptable delivery models. BRICS members combine large and diverse animal-health ecosystems with differing public-health priorities, diagnostic capacity, and reimbursement conditions. The European Union emphasizes animal welfare, laboratory quality, privacy, and regulatory alignment across member states. G7 countries generally have mature clinical infrastructure and strong expectations for evidence-based care, although access and affordability remain important. GCC countries show growing interest in high-quality companion-animal services alongside varied workforce and import requirements. NATO members do not form a uniform veterinary market, but their overlapping preparedness, biosecurity, and institutional cooperation priorities can support attention to surveillance and resilience.

Country Insights: Diverse Priorities Shape Screening Adoption

Australia combines advanced veterinary capability with geographic dispersion, making outreach and remote support relevant. Brazil and Mexico require scalable screening pathways that address regional differences in access and affordability. Canada and the United States have broad diagnostic capabilities, with demand influenced by preventive-care awareness, insurance use, and veterinary workforce pressures. China and India present large, diverse care environments where urban growth coexists with uneven access and a need for education and tiered services. Japan and South Korea emphasize technology-enabled, quality-focused care within aging companion-animal populations. France, Germany, Italy, Spain, and the United Kingdom operate within comparatively mature European systems, with attention to welfare, clinical quality, data protection, and sustainable practice operations. Russia's screening environment is shaped by regional variation, infrastructure differences, and the need for dependable diagnostic access.

Priorities for Leaders Building Trusted Screening Services

Industry leaders should design screening pathways around clinical utility, affordability, and clear communication rather than technology alone. Priority actions include segmenting protocols by life stage and risk, strengthening laboratory quality assurance, training veterinary teams in preventive counseling, and creating referral pathways for abnormal findings. Digital tools should be introduced with prospective validation, human oversight, cybersecurity controls, and transparent explanations for owners and clinicians. Partnerships with practices, laboratories, insurers, shelters, universities, and public-health bodies can improve reach while maintaining appropriate consent and data governance. Performance should be monitored through clinically meaningful measures such as follow-up completion, diagnostic turnaround, preventable disease detection, client understanding, and animal welfare outcomes.

Research Methodology for a Data-Grounded Executive Summary

This executive summary uses the defined Pet Health Screening market scope and synthesizes verified thematic evidence relevant to preventive veterinary care, diagnostics, digital health, artificial intelligence, regional conditions, and institutional priorities. Analysis is structured across the required regions, country groups, and countries, while avoiding unsupported numerical claims. Interpretations should be validated against current veterinary guidelines, peer-reviewed research, regulatory publications, laboratory standards, provider data, and field interviews before being used for investment, product, or policy decisions. Because screening practices differ by species and jurisdiction, conclusions should be tested against local clinical protocols and legal requirements.

Conclusion: Scale Prevention Through Evidence and Access

Pet health screening is moving toward earlier detection, more personalized risk assessment, and digitally supported continuity of care. The strongest opportunities lie in combining reliable diagnostics with practical preventive protocols, skilled veterinary oversight, accessible pricing, and owner education. Artificial intelligence can accelerate this transition when deployed safely and validated clinically, but trust, regulation, workforce capacity, and equitable access remain decisive. Leaders that align innovation with measurable animal-health outcomes will be better positioned to strengthen preventive care across diverse markets and care systems.

Product Code: MRR-961F26FD7FFF

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pet Health Screening Market, by Animal Type

7.1. Introduction
7.2. Cats
- 7.2.1. Adult
- 7.2.2. Kitten
- 7.2.3. Senior
7.3. Dogs
- 7.3.1. Adult
- 7.3.2. Puppy
- 7.3.3. Senior
7.4. Equine
- 7.4.1. Racehorse
- 7.4.2. Working
7.5. Livestock
- 7.5.1. Cattle
- 7.5.2. Poultry
- 7.5.3. Swine

8. Pet Health Screening Market, by Screening Type

8.1. Introduction
8.2. Blood Test
- 8.2.1. Biochemistry
- 8.2.2. Hematology
- 8.2.3. Molecular
- 8.2.4. Serology
8.3. Cardiac Screening
- 8.3.1. ECG
- 8.3.2. Echocardiography
8.4. Dental Exam
- 8.4.1. Advanced Procedures
- 8.4.2. Radiographic Imaging
- 8.4.3. Routine Cleaning
8.5. Endocrine Screening
- 8.5.1. Hormone Assay
- 8.5.2. Stimulation Tests
8.6. Imaging
- 8.6.1. CT
- 8.6.2. MRI
- 8.6.3. Ultrasound
- 8.6.4. X-Ray

9. Pet Health Screening Market, by Technology

9.1. Introduction
9.2. Artificial intelligence
9.3. Machine Learning

10. Pet Health Screening Market, by End-User

10.1. Introduction
10.2. Veterinary Clinics
10.3. Hospitals
10.4. Pet Owners

11. Pet Health Screening Market, by Region

11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa

12. Pet Health Screening Market, by Group

12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO

13. Pet Health Screening Market, by Country

13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea

14. Competitive Landscape

14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
- 14.2.1. Concentration Ratio (CR)
- 14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025

15. Company Profiles

15.1. Covetrus, Inc.
15.2. Heska Corporation
15.3. IDEXX Laboratories, Inc.
15.4. IDvet SAS
15.5. Laboklin GmbH & Co. KG
15.6. Mars, Incorporated
15.7. Merck & Co., Inc.
15.8. Neogen Corporation
15.9. Virbac S.A.
15.10. Zoetis Inc.

16. Key Experts